Pfizer’s Multi-Billion Dollar Acquisition of Metsera: A Key Move to Reshape the Weight-Loss Drug Landscape Sep 26, 2025 Life Science
Opportunities from the Dip? Analyzing Novo Nordisk’s Three Fundamental Pillars Sep 25, 2025 Life Science
Splashing Out 5 Billion! Unveiling Lilly’s Next Growth Engine After the Weight-Loss Injection Sep 24, 2025 Life Science
Positive Results from Investigational Drug Trial, Atai Life Sciences Stock Soars Accordingly Sep 23, 2025 Life Science
Regulatory Tailwinds and Analyst Optimism: A Double Dose of Good News for BioNTech’s Stock Sep 23, 2025 Life Science
Eli Lilly’s Strong Oral Weight-Loss Drug Data Solidifies Its Leading Position in the GLP-1 Market Sep 18, 2025 Life Science
The Tide of the Next Generation: Novo Nordisk’s New Weight-Loss Drug Shows Remarkable Efficacy Sep 17, 2025 Life Science
Who Can Challenge Injectable Weight-Loss Drugs? This Company Is Betting on Pills Sep 13, 2025 Life Science
